Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis. [electronic resource]
Producer: 20040601Description: 144-8; discussion 148-9 p. digitalISSN:- 1527-9995
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Biomarkers, Tumor -- blood
- Bleomycin -- administration & dosage
- Carboplatin -- administration & dosage
- Carcinoma, Embryonal -- drug therapy
- Chemotherapy, Adjuvant
- Combined Modality Therapy
- Disease-Free Survival
- Drug Administration Schedule
- Etoposide -- administration & dosage
- Germinoma -- drug therapy
- Humans
- Lymph Node Excision
- Male
- Neoplasm Invasiveness
- Neoplasm Proteins -- analysis
- Neoplasm Staging
- Neoplasms, Multiple Primary -- drug therapy
- Neoplasms, Second Primary -- drug therapy
- Orchiectomy
- Prognosis
- Risk Factors
- Seminoma -- drug therapy
- Teratoma -- drug therapy
- Testicular Neoplasms -- drug therapy
- Treatment Outcome
- alpha-Fetoproteins -- analysis
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.